White matter changes and its relationship with clinical symptom in medication-naive first-episode early onset schizophrenia

Asian J Psychiatr. 2023 Apr:82:103482. doi: 10.1016/j.ajp.2023.103482. Epub 2023 Jan 24.

Abstract

Previous studies have highlighted the role of white matter (WM) alterations as biomarkers of the disease state and prognosis of schizophrenia. However, less is known about WM abnormalities in the rarely occurring adolescent early onset schizophrenia (EOS). In this study, T1-weighted and diffusion-weighted images were collected in 56 medication-naive first-episode participants with EOS and 43 healthy controls (HCs). Using Tract-based Spatial Statistics, we calculate case-control differences in scalar diffusion measures, i.e. fractional anisotropy (FA) and mean diffusivity (MD), and investigated their association with clinical feature in participants with EOS. Compared with HCs, decreased MD was found in EOS group most notably in the inferior longitudinal fasciculus, anterior thalamic radiation, inferior fronto-occipital fasciculus and corticospinal tract in the right hemisphere. No significant difference was found in FA between these two groups. The FA values of the forceps minor and the right superior longitudinal fasciculus were suggested to be related to the severity of clinical symptom in participants with EOS. These results provide clues about the neural basis of schizophrenia and a potential biomarker for clinical studies.

Keywords: Early-onset schizophrenia; Fractional anisotropy; Mean diffusivity; White matter.

MeSH terms

  • Adolescent
  • Brain / diagnostic imaging
  • Corpus Callosum
  • Diffusion Tensor Imaging / methods
  • Humans
  • Schizophrenia* / diagnostic imaging
  • White Matter* / diagnostic imaging